2022-09-012022-09-012004-12Nak, D. vd. (2004). “Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone”. Australian Veterinary Practitioner, 34(4), 161-162.0310-138Xhttp://hdl.handle.net/11452/28415A case of fibroadenomatous hyperplasia of the mammary gland in a nine-month-old female cat is reported. It was treated with medroxyprogesterone acetate for the suppression of oestrus. Two weeks later. hyperplasia occurred in all mammary glands. The progesterone receptor blocker aglepristone was given sc (10mg/kg) on days 1, 2 and 7. Mammary gland hyperplasia had completely regressed by day 21.eninfo:eu-repo/semantics/closedAccessVeterinary sciencesFelidaeFelis catusEditorial Material0002264616000052-s2.0-13444256138161162344Veterinary sciencesBreast Tumor; Experimental Mammary Neoplasms; Breast NeoplasmsArticleBreast fibroadenomaCatControlled studyEstrusFemaleNonhumanTime series analysisTreatment outcomeTumor regressionAglepristoneAntigestagenMedroxyprogesterone acetateUnclassified drug